Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
A potent human neutralizing antibody Fc-dependently reduces established HBV infections
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
A potent human neutralizing antibody Fc-dependently reduces established HBV infections
Creator
Li, Dan
Li, Wenhui
Du, Kaixin
He, Wenhui
Li, Huiyu
Liu, Juan
Liu, Ximing
Mao, Fengfeng
Pan, Lijing
Qi, Yonghe
Sui, Jianhua
Sun, Yinyan
Ye, Keqiong
Zheng, Sanduo
Source
PMC
abstract
Hepatitis B virus (HBV) infection is a major global health problem. Currently-available therapies are ineffective in curing chronic HBV infection. HBV and its satellite hepatitis D virus (HDV) infect hepatocytes via binding of the preS1 domain of its large envelope protein to sodium taurocholate cotransporting polypeptide (NTCP). Here, we developed novel human monoclonal antibodies that block the engagement of preS1 with NTCP and neutralize HBV and HDV with high potency. One antibody, 2H5-A14, functions at picomolar level and exhibited neutralization-activity-mediated prophylactic effects. It also acts therapeutically by eliciting antibody-Fc-dependent immunological effector functions that impose durable suppression of viral infection in HBV-infected mice, resulting in reductions in the levels of the small envelope antigen and viral DNA, with no emergence of escape mutants. Our results illustrate a novel antibody-Fc-dependent approach for HBV treatment and suggest 2H5-A14 as a novel clinical candidate for HBV prevention and treatment of chronic HBV infection.
has issue date
2017-09-26
(
xsd:dateTime
)
bibo:doi
10.7554/elife.26738
bibo:pmid
28949917
has license
cc-by
sha1sum (hex)
a348cf052e162d6156b8179a82058aff4a0af407
schema:url
https://doi.org/10.7554/elife.26738
resource representing a document's title
A potent human neutralizing antibody Fc-dependently reduces established HBV infections
has PubMed Central identifier
PMC5614562
has PubMed identifier
28949917
resource representing a document's body
covid:a348cf052e162d6156b8179a82058aff4a0af407#body_text
is
schema:about
of
named entity 'NEUTRALIZING ANTIBODY'
named entity 'developed'
named entity 'DNA'
named entity 'viral infection'
named entity 'levels'
named entity 'binding'
named entity 'prophylactic'
named entity 'FUNCTIONS'
named entity 'NTCP'
named entity 'HUMAN'
named entity 'LEVEL'
named entity 'TREATMENT'
named entity 'DOMAIN'
named entity 'PROTEIN '
named entity 'PROPHYLACTIC'
named entity 'PICOMOLAR'
named entity 'ESCAPE'
named entity 'HUMAN'
named entity 'APPROACH'
named entity 'HEPATITIS B VIRUS'
named entity 'BLOCK'
named entity 'HERE'
named entity 'MUTANTS'
named entity 'OUR'
named entity 'VIRAL DNA'
named entity 'ITS'
named entity 'HEALTH PROBLEM'
named entity 'SATELLITE'
named entity 'ENVELOPE PROTEIN'
named entity 'ENVELOPE'
named entity 'NOVEL'
named entity 'CHRONIC'
named entity 'SUPPRESSION'
named entity 'A MAJOR'
named entity 'MONOCLONAL ANTIBODIES'
named entity 'MICE'
named entity 'INFECTIONS'
named entity 'ANTIGEN'
named entity 'DEPENDENT'
named entity 'VIRAL INFECTION'
named entity 'RESULTING IN'
named entity 'BINDING'
named entity 'HEPATOCYTES'
named entity 'EMERGENCE'
named entity 'HBV'
named entity 'A14'
named entity 'IMMUNOLOGICAL'
named entity 'ENGAGEMENT'
named entity 'IS A'
named entity 'INEFFECTIVE'
named entity 'CURRENTLY'
named entity 'HBV'
named entity 'GLOBAL HEALTH'
named entity 'CLINICAL'
named entity 'ESTABLISHED'
named entity 'HEPATITIS D VIRUS'
named entity 'HBV INFECTION'
named entity 'EFFECTS'
named entity 'RESULTS'
named entity 'INFECTION'
named entity 'ANTIBODY'
named entity 'POLYPEPTIDE'
named entity 'POTENCY'
named entity 'CANDIDATE'
named entity 'EFFECTOR'
named entity 'IMPOSE'
named entity 'INFECT'
named entity 'PREVENTION'
named entity 'LEVELS'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 23
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software